Type 1 Diabetes in NOD Mice Unaffected by Mast Cell Deficiency
暂无分享,去创建一个
D. Mathis | A. Liston | A. ortiz-lopez | H. Rodewald | T. Feyerabend | Dario A Gutierrez | Y. Lampi | Susann Schonefeldt | D. Gutierrez | Wenxian Fu | A. Ortíz-López
[1] G. Boeckxstaens,et al. Mast Cells Play No Role in the Pathogenesis of Postoperative Ileus Induced by Intestinal Manipulation , 2014, PloS one.
[2] S. Werner,et al. Mast Cells Are Dispensable for Normal and Activin-Promoted Wound Healing and Skin Carcinogenesis , 2013, The Journal of Immunology.
[3] R. Medzhitov,et al. Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. , 2013, Immunity.
[4] M. Tsai,et al. A beneficial role for immunoglobulin E in host defense against honeybee venom. , 2013, Immunity.
[5] S. Galli,et al. New models for analyzing mast cell functions in vivo. , 2012, Trends in immunology.
[6] M. Tsai,et al. Evidence questioning cromolyn’s effectiveness and selectivity as a ‘mast cell stabilizer’ in mice , 2012, Laboratory Investigation.
[7] H. Rodewald,et al. Widespread immunological functions of mast cells: fact or fiction? , 2012, Immunity.
[8] Rennian Wang,et al. Critical role of c-Kit in beta cell function: increased insulin secretion and protection against diabetes in a mouse model , 2012, Diabetologia.
[9] G. Shi,et al. Different Roles of Mast Cells in Obesity and Diabetes: Lessons from Experimental Animals and Humans , 2012, Front. Immun..
[10] A. Hoerauf,et al. Helminth Protection against Autoimmune Diabetes in Nonobese Diabetic Mice Is Independent of a Type 2 Immune Shift and Requires TGF-β , 2012, The Journal of Immunology.
[11] C. Chen,et al. Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice. , 2011, Blood.
[12] C. Benoist,et al. Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. , 2011, Immunity.
[13] K. Austen,et al. Mast cell deficiency, a game of kit and mouse. , 2011, Immunity.
[14] M. Torrero,et al. Anti-FcεR1 antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice. , 2011, Clinical immunology.
[15] R. Noelle,et al. Mast cells condition dendritic cells to mediate allograft tolerance. , 2011, Immunity.
[16] A. Waisman,et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. , 2011, Immunity.
[17] David M Maahs,et al. Epidemiology of type 1 diabetes. , 2010, Endocrinology and metabolism clinics of North America.
[18] Melissa A Brown,et al. NODckitW/Wv mast cell deficient mice fail to develop type 1 diabetes (135.39) , 2010, The Journal of Immunology.
[19] Jeffrey A. Bluestone,et al. Genetics, pathogenesis and clinical interventions in type 1 diabetes , 2010, Nature.
[20] R. Paus,et al. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. , 2009, Immunity.
[21] C. Benoist,et al. Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. , 2008, The American journal of pathology.
[22] Melissa A Brown,et al. Mast Cells and the Adaptive Immune Response , 2008, Journal of Clinical Immunology.
[23] M. Tsai,et al. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity , 2008, Nature Reviews Immunology.
[24] Melissa A Brown,et al. The master switch: the role of mast cells in autoimmunity and tolerance. , 2008, Annual review of immunology.
[25] Susan M. Schlenner,et al. Molecular mechanism of mast cell–mediated innate defense against endothelin and snake venom sarafotoxin , 2007, The Journal of experimental medicine.
[26] N. Kadowaki,et al. IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells. , 2006, International immunology.
[27] M. Tsai,et al. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. , 2006, Current opinion in immunology.
[28] Å. Lernmark,et al. Evidence of a Functional Role for Mast Cells in the Development of Type 1 Diabetes Mellitus in the BioBreeding Rat1 , 2006, The Journal of Immunology.
[29] Ning Li,et al. Role of different pathways of the complement cascade in experimental bullous pemphigoid. , 2006, The Journal of clinical investigation.
[30] J. Marshall,et al. Mast Cells Have a Pivotal Role in TNF-Independent Lymph Node Hypertrophy and the Mobilization of Langerhans Cells in Response to Bacterial Peptidoglycan1 , 2006, The Journal of Immunology.
[31] C. Chen,et al. Mast Cells Can Enhance Resistance to Snake and Honeybee Venoms , 2006, Science.
[32] M. Tsai,et al. Mast Cell-Associated TNF Promotes Dendritic Cell Migration1 , 2006, The Journal of Immunology.
[33] Tetsuya Tanaka,et al. Effect of mast cell chymase inhibitor on the development of scleroderma in tight‐skin mice , 2005, British journal of pharmacology.
[34] Mark S. Anderson,et al. The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.
[35] Soumitra Ghosh,et al. Involvement of Eotaxin, Eosinophils, and Pancreatic Predisposition in Development of Type 1 Diabetes Mellitus in the BioBreeding Rat1 , 2004, The Journal of Immunology.
[36] J. Marshall,et al. IgE-Mediated Mast Cell Activation Induces Langerhans Cell Migration In Vivo1 , 2004, The Journal of Immunology.
[37] R. Gilbert,et al. Tranilast reduces mesenteric vascular collagen deposition and chymase-positive mast cells in experimental diabetes. , 2004, Journal of diabetes and its complications.
[38] Antonio Lanzavecchia,et al. Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.
[39] S. Pizzo,et al. Mast cell–derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection , 2003, Nature Immunology.
[40] C. Benoist,et al. Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis , 2002, Science.
[41] M. Ludgate,et al. Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease , 2002, Clinical and experimental immunology.
[42] J. Bonnefoy,et al. Histamine Polarizes Human Dendritic Cells into Th2 Cell-Promoting Effector Dendritic Cells , 2001, The Journal of Immunology.
[43] Marek Jutel,et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors , 2001, Nature.
[44] C. Akdis,et al. Histamine Upregulates Th1 and Downregulates Th2 Responses due to Different Patterns of Surface Histamine 1 and 2 Receptor Expression , 2001, International Archives of Allergy and Immunology.
[45] E. Leiter. The NOD Mouse: A Model for Insulin‐Dependent Diabetes Mellitus , 1997, Current protocols in immunology.
[46] C. Gutekunst,et al. Mast Cells Are Essential for Early Onset and Severe Disease in a Murine Model of Multiple Sclerosis , 2000, The Journal of experimental medicine.
[47] N. Maclaren,et al. Autoimmunity and diabetes. , 1999, The Journal of clinical endocrinology and metabolism.
[48] D. Wakefield,et al. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. , 1998, The Journal of clinical investigation.
[49] Kurosawa,et al. Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation , 1998, The British journal of dermatology.
[50] M. Ogawa,et al. Pro-thymocyte expansion by c-kit and the common cytokine receptor gamma chain is essential for repertoire formation. , 1997, Immunity.
[51] A. Zelenetz,et al. The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[52] J. Todd,et al. Genetic control of autoimmune diabetes in the NOD mouse. , 1995, Annual review of immunology.
[53] S. Jewell,et al. Rat peritoneal mast cells present antigen to a PPD-specific T cell line. , 1994, Cellular immunology.
[54] J. Guillet,et al. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. , 1993, Journal of immunology.
[55] F. Levi-Schaffer,et al. Increased numbers of mast cells in pemphigus vulgaris skin lesions. A histochemical study. , 1991, Acta dermato-venereologica.
[56] H. Weiner,et al. Treatment of experimental allergic neuritis with nedocromil sodium , 1989, Journal of Neuroimmunology.
[57] M. Lyon,et al. A new allele sash (Wsh) at the W-locus and a spontaneous recessive lethal in mice. , 1982, Genetical research.
[58] G. Wells,et al. A Histochemical Study , 1966 .